Kategorien
Aktien

Bristol-Myers Squibb Company

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
USD
  • USD
  • BRL
  • ARS
  • EUR
  • MXN
Mitarbeiter 34.300

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von

95 News & Informationen zur Bristol-Myers Squibb Company Aktie

  • Bristol Myers Squibb Completes Sale Of Manufacturing Facility In Couvet, Switzerland
    thestreet.com

    Bristol Myers Squibb Completes Sale Of Manufacturing Facility In Couvet, Switzerland

    Bristol Myers Squibb (NYSE: BMY) today announced that it has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to

  • 12 Best Bear Market Stocks to Buy Now
    insidermonkey.com

    12 Best Bear Market Stocks to Buy Now

    The Centers for Disease Control and Prevention (CDC) in the United States on July 28 asked Americans who had been vaccinated against the coronavirus to start wearing masks in public indoor spaces again…

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    prnewswire.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    /PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…

  • Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
    markets.businessinsider.com

    Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others

    DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…

  • 15 Most Valuable Biotech Companies in the World
    insidermonkey.com

    15 Most Valuable Biotech Companies in the World

    In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…

  • 6 Goldman Sachs Top Stock Picks Also Pay Big-Time Dependable Dividends – 24/7 Wall St.
    247wallst.com

    6 Goldman Sachs Top Stock Picks Also Pay Big-Time Dependable Dividends – 24/7 Wall St.

    These six top Goldman Sachs stock picks all pay healthy dividends and offer great total return potential and less potential volatility in a very overbought stock market that may be poised for a long-needed correction.

  • Bristol Myers Squibb wins European approval for Opdivo in two GIT cancers (NYSE:BMY)
    seekingalpha.com

    Bristol Myers Squibb wins European approval for Opdivo in two GIT cancers (NYSE:BMY)

    Bristol Myers Squibb <> says European Commission ((EC)) has approved Opdivo (nivolumab) for two cancer types in the gastrointestinal tract ((GIT)).Per the decision, Opdivo is…

  • Bfsg, Llc Buys iShares Nasdaq Biotechnology Index Fund, ViacomCBS Inc, Vanguard Energy ETF, Sells iShares Gold Trust, Marvell Technology...
    gurufocus.com

    Bfsg, Llc Buys iShares Nasdaq Biotechnology Index Fund, ViacomCBS Inc, Vanguard Energy ETF, Sells iShares Gold Trust, Marvell Technology Inc, Amazon.com Inc

    GuruFocus Article or News written by insider and the topic is about:

  • 3 Biotech Penny Stocks To Watch On Robinhood IPO Day
    pennystocks.com

  • Unigestion Holding SA Buys Microsoft Corp, Canadian Imperial Bank of Commerce, Facebook Inc, Sells Gilead Sciences Inc, Walmart Inc, C.H....
    gurufocus.com

    Unigestion Holding SA Buys Microsoft Corp, Canadian Imperial Bank of Commerce, Facebook Inc, Sells Gilead Sciences Inc, Walmart Inc, C.H. Robinson Worldwide Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Thursday's morning session saw 167 companies set new 52-week highs.
    Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by …

  • Bristol-Myers Squibb Company 2021 Q2 - Results - Earnings Call Presentation (NYSE:BMY)
    seekingalpha.com

    Bristol-Myers Squibb Company 2021 Q2 – Results – Earnings Call Presentation (NYSE:BMY)

    The following slide deck was published by Bristol-Myers Squibb Company in conjunction with their 2021 Q2 earnings call.

  • Bristol Myers Squibb Earnings: Q2 2021 Shows Strength & Value (NYSE:BMY)
    seekingalpha.com

    Bristol Myers Squibb Earnings: Q2 2021 Shows Strength & Value (NYSE:BMY)

    Bristol Myers Squibb reported strong Q2 earnings results. Despite the competition and its dependence on Revlimid revenue, see why I remain bullish on BMY stock.

  • U.S. Stocks Snap Five-Day Winning Streak Ahead Of Tech Earnings, Fed Announcement
    rttnews.com

    U.S. Stocks Snap Five-Day Winning Streak Ahead Of Tech Earnings, Fed Announcement

    Stocks moved to the downside during trading on Tuesday, giving back ground after closing higher for five consecutive sessions. With the drop on the day, the major averages pulled back off the record closing highs set on Monday.

  • Cordant, Inc. Buys iShares Core MSCI International Developed Markets , Nano X Imaging, FireEye Inc, Sells Ubiquiti Inc, Vericel Corp,...
    gurufocus.com

    Cordant, Inc. Buys iShares Core MSCI International Developed Markets , Nano X Imaging, FireEye Inc, Sells Ubiquiti Inc, Vericel Corp, MiMedx Group Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…

  • Infinity Pharmaceuticals : Reports Second Quarter 2021 Financial Results and Provides Company Update (Form 8-K)
    marketscreener.com

    Infinity Pharmaceuticals : Reports Second Quarter 2021 Financial Results and Provides Company Update (Form 8-K)

    Infinity Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides

    Company Update

    -New clinical data from MARIO-275 and MARIO-3… | July 27, 2021

  • Cathie Wood’s ARK Invest Sells Over 2 Million Shares of KE Holdings – 24
    247wallst.com

    Cathie Wood’s ARK Invest Sells Over 2 Million Shares of KE Holdings – 24

    One of Cathie Wood's Ark Invest funds sold over 2 million shares of KE Holdings on July 23.

  • 3 Warren Buffett Stocks That Are Screaming Summer Buys
    fool.com

    3 Warren Buffett Stocks That Are Screaming Summer Buys

    Riding the Oracle of Omaha's coattails is a moneymaking proposition.

  • Benzinga's Bulls And Bears Of The Week: Amazon, Apple, Bitcoin, GameStop, Netflix And More
    benzinga.com

    Benzinga's Bulls And Bears Of The Week: Amazon, Apple, Bitcoin, GameStop, Netflix And More

    Benzinga has examined the prospects for many investor favorite stocks over the pas…

  • Bristol-Myers Squibb Stock: A Combination Of Value & Growth (NYSE:BMY)
    seekingalpha.com

    Bristol-Myers Squibb Stock: A Combination Of Value & Growth (NYSE:BMY)

    Bristol-Myers Squibb stock features a good combination of value and growth, and offers double digit return potential. Learn more about BMY and healthcare sector.

  • The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
    markets.businessinsider.com

    The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

    Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…

  • Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential (NYSE:BMY)
    seekingalpha.com

    Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential (NYSE:BMY)

    Bristol Myers Squibb is one of the largest pharmaceutical companies backed by a pristine Balance Sheet.

  • Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
    zacks.com

    Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

    Bristol Myers Squibb (BMY) closed at $68.34 in the latest trading session, marking a +0.56% move from the prior day.

  • Foundry Partners, LLC Buys ConocoPhillips, Simon Property Group Inc, Oil States International Inc, Sells W.P. Carey Inc, Cimarex Energy Co,...
    gurufocus.com

    Foundry Partners, LLC Buys ConocoPhillips, Simon Property Group Inc, Oil States International Inc, Sells W.P. Carey Inc, Cimarex Energy Co, First Midwest Bancorp Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Antibody Market Expected to Reach USD 318,482.1 Million by 2027, With a CAGR Of 10.1% | Growth Market Reports
    prnewswire.com

    Global Antibody Market Expected to Reach USD 318,482.1 Million by 2027, With a CAGR Of 10.1% | Growth Market Reports

    /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Global Antibody Market by Types, (Monoclonal Antibodies,…

  • PrairieView Partners, LLC Buys Schwab Fundamental International Small Company Ind, Vanguard Tax-Exempt Bond ETF, iShares MSCI USA ESG...
    gurufocus.com

    PrairieView Partners, LLC Buys Schwab Fundamental International Small Company Ind, Vanguard Tax-Exempt Bond ETF, iShares MSCI USA ESG Optimized ETF, Sells iShares Short-Term National Muni Bond ETF, Xc

    GuruFocus Article or News written by insider and the topic is about:

  • Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
    zacks.com

    Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know

    Bristol Myers Squibb (BMY) closed the most recent trading day at $67.96, moving +1.19% from the previous trading session.

  • 2 Dirt Cheap Dividend Stocks You Can Buy Right Now
    fool.com

  • Bristol Myers Squibb (BMY) Earnings Expected to Grow: Should You Buy?
    zacks.com

    Bristol Myers Squibb (BMY) Earnings Expected to Grow: Should You Buy?

    Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Unilever PLC (UL) Fell Out Of Favor With Hedge Funds
    insidermonkey.com

    Unilever PLC (UL) Fell Out Of Favor With Hedge Funds

    Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed…

  • BHP Group (BBL): Are Hedge Funds Right About This Stock?
    insidermonkey.com

    BHP Group (BBL): Are Hedge Funds Right About This Stock?

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…

  • Have $1,000? 2 Warren Buffett Stocks to Buy
    fool.com

    Have $1,000? 2 Warren Buffett Stocks to Buy

    Don't miss out on these top stocks owned by none other than the Oracle of Omaha.

  • Bristol Myers Squibb (BMY) Stock Moves -0.19%: What You Should Know
    zacks.com

    Bristol Myers Squibb (BMY) Stock Moves -0.19%: What You Should Know

    Bristol Myers Squibb (BMY) closed the most recent trading day at $67.30, moving -0.19% from the previous trading session.

  • 10 Best Blue Chip Dividend Stocks Hedge Funds Are Buying
    insidermonkey.com

    10 Best Blue Chip Dividend Stocks Hedge Funds Are Buying

    In this article, we will be looking at the 10 best blue chip dividend stocks hedge funds are buying. To skip our detailed analysis of blue-chip stocks…

  • The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
    markets.businessinsider.com

    The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…

  • 3 Stocks To Buy In A 'Risk-Off' Market
    investing.com

    3 Stocks To Buy In A 'Risk-Off' Market

    Stocks Analysis by MarketBeat.com (Sean Sechler) covering: Coca-Cola Co, Merck & Company Inc, Colgate-Palmolive Company, Duke Energy Corporation. Read MarketBeat.com (Sean Sechler)'s latest article on Investing.com

  • Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
    zacks.com

    Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

    In the latest trading session, Bristol Myers Squibb (BMY) closed at $67.43, marking a -0.66% move from the previous day.

  • GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
    forbes.com

    GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022

    The company operates in three major business segments, Pharmaceuticals, Vaccines and Consumer Healthcare.

  • Beech Hill Advisors, Inc. Buys Delta Air Lines Inc, Airbnb Inc, Darden Restaurants Inc, Sells Starbucks Corp, Cisco Systems Inc, Blackstone...
    gurufocus.com

    Beech Hill Advisors, Inc. Buys Delta Air Lines Inc, Airbnb Inc, Darden Restaurants Inc, Sells Starbucks Corp, Cisco Systems Inc, Blackstone Group Inc

    GuruFocus Article or News written by insider and the topic is about:

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Bristol-Myers Squibb Company?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Bristol-Myers Squibb Company?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Bristol-Myers Squibb Company?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Bristol-Myers Squibb Company?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect